D68.318

D68.318: Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors

Billable / specific codeICD-10-CM

D68.318 is a billable, specific ICD-10-CM code for other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors. It is valid for submission on a claim.

Check D68.318 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Antithromboplastinemia
Antithromboplastinogenemia
Hemorrhagic disorder due to intrinsic increase in antithrombin
Hemorrhagic disorder due to intrinsic increase in anti-VIIIa
Hemorrhagic disorder due to intrinsic increase in anti-IXa
Hemorrhagic disorder due to intrinsic increase in anti-XIa

Excludes1 inherited from the categories above D68.318

A category’s note binds every code beneath it.

Written on D68: Other coagulation defects

abnormal coagulation profile NOS (R79.1)

Excludes2 inherited from the categories above D68.318

Not part of this code, but both may be coded when both are present.

Written on D68: Other coagulation defects

coagulation defects complicating abortion or ectopic or molar pregnancy (O00-O07, O08.1)
coagulation defects complicating pregnancy, childbirth and the puerperium (O45.0, O46.0, O67.0, O72.3)

Other codes that can never be billed with D68.318

Their own Excludes1 notes name this code, so the conflict is not listed above.

R79.1Abnormal coagulation profile

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

D68.318 is named in 2 Medicare coverage policies: 2 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A56065Billing and Coding: Guidance for Anti-Inhibitor Coagulant Complex (AICC) National Coverage Determination (NCD) 110.3
A57954Billing and Coding: Routine Foot Care

Alphabetic index entries that lead here

Anticoagulant, circulating(intrinsic)
Antithromboplastinemia
Antithromboplastinogenemia
Circulating anticoagulants
Disorder›hemorrhagic NEC›due to›intrinsic›circulating anticoagulants
Disorder›hemorrhagic NEC›due to›intrinsic›increase in›anti-IXa
Disorder›hemorrhagic NEC›due to›intrinsic›increase in›anti-VIIIa
Disorder›hemorrhagic NEC›due to›intrinsic›increase in›anti-XIa
Disorder›hemorrhagic NEC›due to›intrinsic›increase in›antithrombin

Code history

Unchanged in every release from FY2024 to FY2027.